Affirm Contrast Biopsy
System, X-Ray, Mammographic. 510(k) K202294, from Hologic, Inc. (Danbury, CT). Product code IZH, class 2.
As of Nov 20, 2026, K202294 is an FDA 510(k) held by Hologic, Inc., substantially equivalent on Oct 5, 2020 after 53 days, with no recalls tied to it in FDA's recall database.
- Review time: 53 days
- Recalls: 0
Affirm® Contrast Biopsy is indicated as an optional accessory for the Selenia Dimensions 2D Full Field Digital Mammography System and 3Dimensions system. It is designed to allow the accurate location of lesions in the breast in three dimensions, using information extracted from stereotactic pairs of two-dimensional images.
- Affirm Breast Biopsy Guidance SystemK103512 · Hologic, Inc. · Jan 7, 2011
- Smart FinderK203509 · Ims Giotto S.P.A. · Jul 14, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Aug 13, 2020
- Review panel
- Radiology
- Regulation
- 21 CFR 892.1710
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files